Lixing Yang to Poly(ADP-ribose) Polymerase Inhibitors
This is a "connection" page, showing publications Lixing Yang has written about Poly(ADP-ribose) Polymerase Inhibitors.
Connection Strength
0.212
-
Synthetic Lethal Targeting of CDK12-Deficient Prostate Cancer with PARP Inhibitors. Clin Cancer Res. 2024 Dec 02; 30(23):5445-5458.
Score: 0.212
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.